& Gerich, J
The regulatory framework for compounded pharmaceuticals does not extend to investigational research peptides, and a vendor association with compounding does not guarantee research peptide quality
Some patients aim to reach a target weight and then transition to maintenance dosing, while others view semaglutide as a permanent part of their metabolic health toolkit
As there are now several published articles on Semaglutide on weight, we are aiming to focus our attention on the effects of this drug on body composition, so only studies that have measured body composition via DEXA are of interest to us This way, we can separate the effects of these drugs on fat mass and lean muscle mass
Protein shakes designed for GLP-1 users can help when solid food feels challenging during periods of strong appetite suppression
The dominant clinical question is whether these benefits are downstream consequences of weight loss, glycemic improvement, and blood-pressure reduction, or whether they reflect direct pleiotropic actions on the vascular wall and myocardium